文献速递核素与放射性配体治疗肿瘤 PET/CT

当前体外与体内模型概览及其对靶向放射性核素诊疗的相关性

Exploring the landscape of current in vitro and in vivo models and their relevance for targeted radionuclide theranostics.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-02-28

该叙述性综述梳理了肿瘤研究中常用的体外、离体和体内模型,包括二维与三维细胞模型、球体、类器官、组织切片培养以及小鼠肿瘤模型,讨论这些模型目前在靶向放射性核素诊疗研究中的应用情况,并指出需要应用更先进的模型以更好反映交叉火力和远隔效应等靶向放射性核素诊疗特有现象。

要点

  • 综述涵盖二维与三维细胞模型、球体、类器官、组织切片培养及小鼠肿瘤模型。
  • 各模型在研究人类肿瘤生物学、放射性药物评估和治疗疗效方面各有优势与局限。
  • 靶向放射性核素诊疗研究需应用更先进模型以更好反映交叉火力与远隔效应。

核心结论

  • 总体而言,靶向放射性核素诊疗研究需要应用更先进的模型,以更好反映交叉火力和远隔效应等靶向放射性核素诊疗特有现象,从而提高临床前靶向放射性核素诊疗评估的临床相关性和有效性。

研究设计与样本

  • 叙述性综述,检视当前用于肿瘤研究的体外、离体和体内模型,并讨论这些模型目前是否及如何应用于靶向放射性核素诊疗研究,以及尚未应用的模型能否对该领域有益。

主要发现

  • 讨论的模型包括体外二维和三维细胞模型(含球体、类器官和组织切片培养)以及体内小鼠肿瘤模型(含细胞系来源模型、患者来源异种移植模型和人源化模型)。
  • 每种模型在研究人类肿瘤生物学、放射性药物评估和治疗疗效方面各有优势和局限性。
  • 靶向放射性核素诊疗领域相对较新,更先进的临床前模型尚未在靶向放射性核素诊疗研究中常规应用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cancer remains a leading cause of mortality globally, driving ongoing research into innovative treatment strategies. Preclinical research forms the base for developing these novel treatments, using both in vitro and in vivo model systems that are, ideally, as clinically representative as possible. Emerging as a promising approach for cancer management, targeted radionuclide theranostics (TRT) uses radiotracers to deliver (cytotoxic) radionuclides specifically to cancer cells. Since the field is relatively new, more advanced preclinical models are not yet regularly applied in TRT research. This narrative review examines the currently applied in vitro, ex vivo and in vivo models for oncological research, discusses if and how these models are now applied for TRT studies, and whether not yet applied models can be of benefit for the field. A selection of different models is discussed, ranging from in vitro two-dimensional (2D) and three-dimensional (3D) cell models, including spheroids, organoids and tissue slice cultures, to in vivo mouse cancer models, such as cellline-derived models, patient-derived xenograft models and humanized models. Each of the models has advantages and limitations for studying human cancer biology, radiopharmaceutical assessment and treatment efficacy. Overall, there is a need to apply more advanced models in TRT research that better address specific TRT phenomena, such as crossfire and abscopal effects, to enhance the clinical relevance and effectiveness of preclinical TRT evaluations.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Bokhout L, Campeiro JD, Dalm SU, et al. Exploring the landscape of current in vitro and in vivo models and their relevance for targeted radionuclide theranostics. Eur J Nucl Med Mol Imaging. 2025. PMID: 40016527. doi:10.1007/s00259-025-07123-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。